Somewhat irrelevant at this point. The peptides are sold freely in other countries as substances with which to experiment in petri dishes. Not for use on humans. I repeat - not for use on humans.

The worst thing about these drugs hitting the pharma market in recent years is that it has sucked the air out of the room for other investment due to their immense profitability. So much cutting edge talent is being squandered to work on these weight loss drugs because they pay the bills better than solving rare disease. I've heard a direct quote from a pharma product manager in person: "we don't look for cures, we look for treatments." You know, because cure implies a one time payment.

Talk about perverse incentive.